Aim 1 addresses the role of estrogen response elements in determining gene activation. The hypothesis addresses whether DNA binding acts as an allosteric effector to direct ER conformation which in turn leads to recruitment of coactivators or corepressors. The role of ER affinity for particular EREs and the induction of different conformations by the ERE that alters ER interaction with coregulators will be investigated. The effect of increased ER binding to the ERE will be determined in relation to coregulator interaction and transactivation when bound to estradiol and 4-hydroxytamoxifen. ER domains involved in communicating specific ERE binding to coregulator interactions will be established.
Aim 2 makes use of ER bound to different imperfect EREs to determine the effect of exchanging EREs in native promoters to test coregulator recruitment, activity in cell-free transcription assays and in transiently and stably transfected cell lines.
In aim 3, a cell free system of deproteinized templates will be used to identify rate limiting ER coregulators. A chromatin assembly system is proposed to test the effects of DNA replication, nucleosome assembly and position, cell specific factors, and histone deacetylation.
In aim 4, stably transfected ER+ HepG2 cells will be used to test whether elongation rather than initiation is limiting in ER induction of vitellogenin gene expression. Chromatin immunoprecipitation assays will be performed to identify differences in the patterns of ER and HNF3a binding and histone acetylation when transcription of the estrogen inducible VIT and PI-9 promoters is weakly or strongly activated.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project (R01)
Project #
2R01HD016720-19A1
Application #
6262644
Study Section
Biochemical Endocrinology Study Section (BCE)
Program Officer
Yoshinaga, Koji
Project Start
1982-07-01
Project End
2006-03-31
Budget Start
2001-04-01
Budget End
2002-03-31
Support Year
19
Fiscal Year
2001
Total Cost
$267,161
Indirect Cost
Name
University of Illinois Urbana-Champaign
Department
Biochemistry
Type
Schools of Arts and Sciences
DUNS #
041544081
City
Champaign
State
IL
Country
United States
Zip Code
61820
Zhou, Jian-Hua; Yu, David V; Cheng, Jingwei et al. (2007) Delayed and persistent ERK1/2 activation is required for 4-hydroxytamoxifen-induced cell death. Steroids 72:765-77
Cheng, Jingwei; Yu, David V; Zhou, Jian-Hua et al. (2007) Tamoxifen induction of CCAAT enhancer-binding protein alpha is required for tamoxifen-induced apoptosis. J Biol Chem 282:30535-43
Cheng, Jingwei; Zhang, Chen; Shapiro, David J (2007) A functional serine 118 phosphorylation site in estrogen receptor-alpha is required for down-regulation of gene expression by 17beta-estradiol and 4-hydroxytamoxifen. Endocrinology 148:4634-41
Jiang, X; Ellison, S J; Alarid, E T et al. (2007) Interplay between the levels of estrogen and estrogen receptor controls the level of the granzyme inhibitor, proteinase inhibitor 9 and susceptibility to immune surveillance by natural killer cells. Oncogene 26:4106-14
Wang, Stanley; Zhang, Chen; Nordeen, Steven K et al. (2007) In vitro fluorescence anisotropy analysis of the interaction of full-length SRC1a with estrogen receptors alpha and beta supports an active displacement model for coregulator utilization. J Biol Chem 282:2765-75
Jiang, Xinguo; Orr, Brent A; Kranz, David M et al. (2006) Estrogen induction of the granzyme B inhibitor, proteinase inhibitor 9, protects cells against apoptosis mediated by cytotoxic T lymphocytes and natural killer cells. Endocrinology 147:1419-26
Krieg, Adam J; Krieg, Sacha A; Ahn, Bonnie S et al. (2004) Interplay between estrogen response element sequence and ligands controls in vivo binding of estrogen receptor to regulated genes. J Biol Chem 279:5025-34
Wang, Stanley Y; Ahn, Bonnie S; Harris, Rebecca et al. (2004) Fluorescence anisotropy microplate assay for analysis of steroid receptor-DNA interactions. Biotechniques 37:807-8, 810-7
Kannan-Thulasiraman, Padma; Shapiro, David J (2002) Modulators of inflammation use nuclear factor-kappa B and activator protein-1 sites to induce the caspase-1 and granzyme B inhibitor, proteinase inhibitor 9. J Biol Chem 277:41230-9
Krieg, S A; Krieg, A J; Shapiro, D J (2001) A unique downstream estrogen responsive unit mediates estrogen induction of proteinase inhibitor-9, a cellular inhibitor of IL-1beta- converting enzyme (caspase 1). Mol Endocrinol 15:1971-82

Showing the most recent 10 out of 47 publications